It was shown that the Adora2b, inhibitor PSB1115 reduced the number of CAFs expressing fibroblast activating protein (FAP) and fibroblast growth factor (FGF-2) in the tumor microenvironment of melanoma mice (101). This evidence concerns the gene FGF2 and neoplasm.